StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Moderna, Inc.
NasdaqGS:MRNA
Sector
Industries
Location
Market Cap
USD 13.26 B
Share Price
USD 34.28
Avg Daily Volume
10,729,633
Change (1 day)
4.54%
Change (1 year)
-70.81%
Change (YTD)
-17.56%
Moderna, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -3.05 B
Moderna, Inc. Operating Cash Flow is USD -3.05 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.90% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Moderna, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -2.88 B, a -390.23% change year over year.
-
Moderna, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 993.00 M, a -92.60% change year over year.
-
Moderna, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 13.41 B, a 162.77% change year over year.
-
Moderna, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 5.10 B, a -1,311.72% change year over year.
Competitors
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
-0.05
-0.62%
Swedish Orphan Biovitrum AB (publ)
USD 30.75
SOBI.ST
+1.06
3.56%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.87
300122.SZ
+0.09
3.15%
Ionis Pharmaceuticals, Inc.
USD 42.38
IONS
-0.45
-1.05%
Rhythm Pharmaceuticals, Inc.
USD 89.04
RYTM
+0.04
0.04%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.93
1877.HK
-0.07
-2.30%
Vaxcyte, Inc.
USD 36.24
PCVX
+0.46
1.29%
Hualan Biological Engineering Inc.
USD 2.21
002007.SZ
+0.01
0.57%
NewAmsterdam Pharma Company N.V.
USD 22.02
NAMS
+0.38
1.76%
Apellis Pharmaceuticals, Inc.
USD 19.53
APLS
+0.32
1.67%
Ligand Pharmaceuticals Incorporated
USD 124.98
LGND
+2.58
2.11%
Bavarian Nordic A/S
USD 28.76
BAVA.CO
+1.24
4.51%
Apogee Therapeutics, Inc.
USD 38.57
APGE
+1.55
4.19%
Adaptive Biotechnologies Corporation
USD 12.08
ADPT
+0.15
1.26%
ARS Pharmaceuticals, Inc.
USD 17.98
SPRY
+0.08
0.45%
Immunocore Holdings plc
USD 35.45
IMCR
+0.87
2.52%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
-0.05
-0.62%
Swedish Orphan Biovitrum AB (publ)
USD 30.75
SOBI.ST
+1.06
3.56%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.87
300122.SZ
+0.09
3.15%
Ionis Pharmaceuticals, Inc.
USD 42.38
IONS
-0.45
-1.05%
Rhythm Pharmaceuticals, Inc.
USD 89.04
RYTM
+0.04
0.04%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.93
1877.HK
-0.07
-2.30%
Vaxcyte, Inc.
USD 36.24
PCVX
+0.46
1.29%
Hualan Biological Engineering Inc.
USD 2.21
002007.SZ
+0.01
0.57%
NewAmsterdam Pharma Company N.V.
USD 22.02
NAMS
+0.38
1.76%
Apellis Pharmaceuticals, Inc.
USD 19.53
APLS
+0.32
1.67%
Ligand Pharmaceuticals Incorporated
USD 124.98
LGND
+2.58
2.11%
Bavarian Nordic A/S
USD 28.76
BAVA.CO
+1.24
4.51%
Apogee Therapeutics, Inc.
USD 38.57
APGE
+1.55
4.19%
Adaptive Biotechnologies Corporation
USD 12.08
ADPT
+0.15
1.26%
ARS Pharmaceuticals, Inc.
USD 17.98
SPRY
+0.08
0.45%
Immunocore Holdings plc
USD 35.45
IMCR
+0.87
2.52%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%